Depot Buprenorphine Injection in the Management of Opioid Use Disorder: From Development to Implementation (vol 10, pg 69, 2019)

被引：0
|
作者：
Ling, W.
Shoptaw, S.
Goodman-Meza, D.
机构：
来源：
SUBSTANCE ABUSE AND REHABILITATION | 2020年 / 11卷
关键词：
D O I：
10.2147/SAR.S247083
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页码：19 / 20
页数：2
相关论文
共 50 条
  • [31] Maternal Opioid Use Disorder and Neonatal Abstinence Syndrome Among Rural US Residents, 2007-2014 (vol 35, pg 122, 2019)
    Kozhimannil, Katy B.
    Chantarat, Tongtan
    Ecklund, Alexandra M.
    Henning-Smith, Carrie
    Jones, Cresta
    JOURNAL OF RURAL HEALTH, 2020, 36 (01): : 137 - 137
  • [32] Contingency Management for Patients Receiving Medication for Opioid Use Disorder: A Systematic Review and Meta-analysis (vol 78, pg 1092, 2021)
    Bolivar, H. A.
    Klemperer, E. M.
    Coleman, S. R. M.
    DeSarno, M.
    Skelly, J. M.
    Higgins, S. T.
    JAMA PSYCHIATRY, 2023, 80 (11) : 1176 - 1176
  • [33] Contingency management for patients receiving medication for opioid use disorder: a systematic review and meta-analysis (vol 78, pg 1092, 2021)
    Bolivar, H. A.
    Klemperer, E. M.
    Coleman, S. R. M.
    DeSarno, M.
    Skelly, J. M.
    Higgins, S. T.
    JAMA PSYCHIATRY, 2022, 79 (03) : 272 - 272
  • [34] Rapid buprenorphine microdosing for opioid use disorder in a hospitalized patient receiving very high doses of full agonist opioids for acute pain management: Titration, implementation barriers, and strategies to overcomes
    DeWeese, Jonathan P.
    Krenz, James R.
    Wakeman, Sarah E.
    Peckham, Alyssa M.
    SUBSTANCE ABUSE, 2021, 42 (04) : 506 - 511
  • [35] Association of Cohort and Individual Substance Use With Risk of Transitioning to Drug Use, Drug Use Disorder, and Remission From Disorder: Findings From the World Mental Health Surveys (vol 76, pg 708, 2019)
    de Girolamo, Giovanni
    JAMA PSYCHIATRY, 2019, 76 (07) : 768 - 768
  • [36] Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network
    Wu, Li-Tzy
    John, William S.
    Ghitza, Udi E.
    Wahle, Aimee
    Matthews, Abigail G.
    Lewis, Mitra
    Hart, Brett
    Hubbard, Zach
    Bowlby, Lynn A.
    Greenblatt, Lawrence H.
    Mannelli, Paolo
    ADDICTION, 2021, 116 (07) : 1805 - 1816
  • [37] Defining Recovery From Alcohol Use Disorder: Development of an NIAAA Research Definition (vol 179, pg 807, 2022)
    Hagman, Brett T.
    AMERICAN JOURNAL OF PSYCHIATRY, 2022, 179 (11): : 813 - 813
  • [38] Changes in US Clinician Waivers to Prescribe Buprenorphine Management for Opioid Use Disorder During the COVID-19 Pandemic and After Relaxation of Training Requirements (vol 5, e225996, 2022)
    不详
    JAMA NETWORK OPEN, 2023, 6 (07)
  • [39] Opioid Use Disorder Among Ohio's Medicaid Population: Prevalence Estimates From 19 Counties Using a Multiplier Method (Vol 191, pg 2098, 2022)
    Doogan, Nathan J.
    Mack, Aimee
    Wang, Jianing
    Crane, Dushka
    Jackson, Rebecca
    Applegate, Mary
    Villani, Jennifer
    Chandler, Redonna
    Barocas, Joshua A.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2023,
  • [40] Impact of outpatient pharmacist dispensing in an opioid use disorder clinic (Reprinted from J Am Pharm Assoc, vol 64, pg 530-534, 2024)
    Piehl, Emma
    Veach, Stevie
    Powers, Amanda
    Otting, Rachel
    Smith, Jess
    Polgreen, Linnea A.
    Wolff, Kaley
    Witry, Matthew J.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2024, 64 (04)
12345